The availability of ACCUTRACE™ PLUS, despite it being under patent cover in the Union, should be secured, where appropriate, by licensing agreements.
Recital 10, Decision_act (EU) 2022/197
In forcesince 17 Jan 2022
The availability of ACCUTRACE™ PLUS, despite it being under patent cover in the Union, should be secured, where appropriate, by licensing agreements.